Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease
Open Access
- 11 November 2008
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 275 (23), 5767-5773
- https://doi.org/10.1111/j.1742-4658.2008.06709.x
Abstract
Heterozygous loss‐of‐function mutations at the glucosecerebrosidase locus have recently been shown to be a potent risk factor for Lewy body disease. Based on this observation, we have re‐evaluated the likelihood that the different PARK loci (defined using clinical criteria for disease) may be misleading attempts to find common pathways to pathogenesis. Rather, we suggest, grouping the different loci which lead to different Lewy body disease may be more revealing. Doing this, we suggest that several of the genes involved in disparate Lewy body diseases impinge on ceramide metabolism and we suggest that this may be a common theme for pathogenesis.Keywords
This publication has 58 references indexed in Scilit:
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular AutophosphorylationPublished by Elsevier BV ,2008
- Glucocerebrosidase Gene MutationsArchives of Neurology, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Complete screening for glucocerebrosidase mutations in Parkinson disease patients from PortugalNeurobiology of Aging, 2007
- The Group VIA Calcium-Independent Phospholipase A2 Participates in ER Stress-Induced INS-1 Insulinoma Cell Apoptosis by Promoting Ceramide Generation via Hydrolysis of Sphingomyelins by Neutral SphingomyelinaseBiochemistry, 2007
- PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain ironNature Genetics, 2006
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998